Bendamustine-Based Therapy as First-Line Treatment for Non-Hodgkin Lymphoma

Medical Oncology - United States
doi 10.1007/s12032-014-0944-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC